CAC Camden National (CAC) Insider Trading, Ownership & Congress Trades
Banks · National commercial banks · CIK 0000750686
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
Camden National insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
No insider purchases or sales are on record for CAMDEN NATIONAL CORP in the period covered. Source: SEC Form 4 filings, as of 2026-10-27.
Insider
Filed
Shares
Value
Since filing
Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 18.2% of the 562 shares held after it.
- No other insider bought within 30 days.
Insider activity: Director Maxwell Raina bought about $4.1K of CAC on May 28, 2025, the largest insider purchase at the company since 2023.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 5.2% of the 9,614 shares held after it.
- No other insider sold within 30 days.
Insider activity: Director Merrill Robert D sold about $22.0K of CAC on Feb 4, 2025, the largest insider sale at the company on our record.Context
- 4 earlier Form 4 trades (code P or S) here by this insider (4 buys), the last on Jun 17, 2022.
- +2.1% median (+0.9% mean) 90-day return after 4 previous buys.
- The trade is 13.3% of the 25,554 shares held after it.
- No other insider bought within 30 days.
Insider activity: Director Flanagan David C bought about $99.7K of CAC on May 11, 2023, the largest insider purchase at the company on our record.Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Mar 10, 2022.
- The trade is 1.8% of the 16,557 shares held after it.
- No other insider sold within 30 days.
Insider activity: EVP Smyth Renee sold about $13.9K of CAC on Aug 19, 2022, the largest insider sale at the company on our record.Context
- 3 earlier Form 4 trades (code P or S) here by this insider (3 buys), the last on Mar 18, 2022.
- +0.9% median (+0.1% mean) 90-day return after 3 previous buys.
- The trade is 1.7% of the 20,149 shares held after it.
- 4 other insiders bought within 30 days.
Insider activity: Director Flanagan David C bought about $15.5K of CAC on Jun 17, 2022; 4 other insiders bought within 30 days.32 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
+17.0% year over year
more than 80% of Banks
Margin
156.1% net margin
below 52% of Banks
Buybacks
$4.0M repurchased, FY to 2026-06-30
below 56% of Banks
Short interest
4.5% of the float short (float per yahoo 2026-10-26) · 7.0 days to cover · settled 2026-09-30
more than 70% of Banks
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch CAC
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+61.6%12M
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns CAC: institutional holders (13F)
13F holdings, latest reported quarter
SEC 13F
No reported 13F holders
No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.
Congress trades in CAC
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
CAC planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Executive pay vs shareholder return · Simon R. Griffiths
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$2.3M
$2.5M
$759.4K
+49%
+60%
2024
$1.9M
$2.0M
$622.1K
+14%
+32%
2023
$1.5M
$1.4M
$803.6K
-5%
+12%
2022
$1.3M
$1.6M
$512.0K
+0%
+11%
2021
$2.4M
$2.3M
$594.1K
+12%
+26%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
Each figure here is a federal filing, dated the day it went public, so you can test what was knowable then.
CAC financials
Revenue growth
+17.0%
XBRL, annual
Net margin
156.1%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$42.8M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM CAC
| FY Dec 2025 | $41.7M |
| FY Dec 2024 | $35.7M |
| FY Dec 2023 | $33.6M |
| FY Dec 2022 | $33.3M |
| FY Dec 2021 | $32.0M |
| Jun 2026 | $11.2M |
| Mar 2026 | $9.7M |
| Dec 2025 | $11.3M |
| Sep 2025 | $10.6M |
| Jun 2025 | $10.4M |
| Mar 2025 | $9.5M |
| Dec 2024 | $9.4M |
| Sep 2024 | $9.1M |
At each fiscal year end
Single quarter
Net margin, TTM
+207.1%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM CAC
| FY Dec 2025 | +156.1% |
| FY Dec 2024 | +148.5% |
| FY Dec 2023 | +129.2% |
| FY Dec 2022 | +184.7% |
| FY Dec 2021 | +216.0% |
| Jun 2026 | +205.4% |
| Mar 2026 | +224.9% |
| Dec 2025 | +199.5% |
| Sep 2025 | +200.8% |
| Jun 2025 | +135.9% |
| Mar 2025 | +77.0% |
| Dec 2024 | +156.4% |
| Sep 2024 | +144.0% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$102.5M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM CAC
| FY Dec 2025 | $58.2M |
| FY Dec 2024 | $55.4M |
| FY Dec 2023 | $64.9M |
| FY Dec 2022 | $103.0M |
| FY Dec 2021 | $140.9M |
| Jun 2026 | $29.9M |
| Mar 2026 | $18.2M |
| Dec 2025 | $19.0M |
| Sep 2025 | $35.4M |
| Jun 2025 | $4.5M |
| Mar 2025 | -$727.0K |
| Dec 2024 | $41.2M |
| Sep 2024 | -$16.2M |
At each fiscal year end
Single quarter
Debt to equity
0.70x
long-term 2021-09-30 (57 months older than the period end) plus current 2026-06-30; equity 2026-06-30
Debt to equity CAC
| FY Dec 2025 | 0.84x |
| FY Dec 2024 | 0.94x |
| FY Dec 2023 | 0.98x |
| FY Dec 2022 | 0.59x |
| FY Dec 2021 | 0.39x |
| Jun 2026 | 0.70x |
| Mar 2026 | 0.72x |
| Dec 2025 | 0.84x |
| Sep 2025 | 1.11x |
| Jun 2025 | 0.92x |
| Mar 2025 | 0.89x |
| Dec 2024 | 0.94x |
| Sep 2024 | 0.97x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.21x
TTM operating cash flow over long-term 2021-09-30 (57 months older than the period end) plus current 2026-06-30
Cash flow to debt CAC
| FY Dec 2025 | 0.11x |
| FY Dec 2024 | 0.12x |
| FY Dec 2023 | 0.14x |
| FY Dec 2022 | 0.40x |
| FY Dec 2021 | 0.67x |
| Jun 2026 | 0.21x |
| Mar 2026 | 0.16x |
| Dec 2025 | 0.11x |
| Sep 2025 | 0.12x |
| Jun 2025 | 0.06x |
| Mar 2025 | 0.08x |
| Dec 2024 | 0.12x |
| Sep 2024 | 0.01x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+12.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity CAC
| FY Dec 2025 | +10.6% |
| FY Dec 2024 | +10.3% |
| FY Dec 2023 | +9.2% |
| FY Dec 2022 | +12.4% |
| FY Dec 2021 | +12.9% |
| Jun 2026 | +12.9% |
| Mar 2026 | +11.8% |
| Dec 2025 | +10.6% |
| Sep 2025 | +9.5% |
| Jun 2025 | +8.5% |
| Mar 2025 | +8.2% |
| Dec 2024 | +10.3% |
| Sep 2024 | +9.4% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+1.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets CAC
| FY Dec 2025 | +1.0% |
| FY Dec 2024 | +0.9% |
| FY Dec 2023 | +0.8% |
| FY Dec 2022 | +1.1% |
| FY Dec 2021 | +1.3% |
| Jun 2026 | +1.3% |
| Mar 2026 | +1.1% |
| Dec 2025 | +1.0% |
| Sep 2025 | +0.9% |
| Jun 2025 | +0.8% |
| Mar 2025 | +0.7% |
| Dec 2024 | +0.9% |
| Sep 2024 | +0.8% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital CAC
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed CAC
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
11.20x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing CAC
| FY Dec 2025 | 11.30x |
| FY Dec 2024 | 11.81x |
| FY Dec 2023 | 12.67x |
| FY Dec 2022 | 10.00x |
| FY Dec 2021 | 10.47x |
| Jun 2026 | 10.39x |
| Mar 2026 | 10.10x |
| Dec 2025 | 11.30x |
| Sep 2025 | 10.99x |
| Jun 2025 | 12.84x |
| Mar 2025 | 12.89x |
| Dec 2024 | 11.81x |
| Sep 2024 | 12.91x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$1.4B
market value at close 2026-10-26 on 2026-07-30 shares, plus long-term 2021-09-30 (57 months older than the period end) plus current 2026-06-30, minus cash 2019-03-31
Enterprise value CAC
| FY Dec 2025 | $1.2B |
| FY Dec 2024 | $984.1M |
| FY Dec 2023 | $893.9M |
| FY Dec 2022 | $732.8M |
| FY Dec 2021 | $787.2M |
| Jun 2026 | $1.3B |
| Mar 2026 | $1.2B |
| Dec 2025 | $1.2B |
| Sep 2025 | $1.3B |
| Jun 2025 | $1.1B |
| Mar 2025 | $1.1B |
| Dec 2024 | $984.1M |
| Sep 2024 | $979.0M |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+10.4%
TTM free cash flow over market value at close 2026-10-26
FCF yield CAC
| FY Dec 2025 | +7.9% |
| FY Dec 2024 | +8.9% |
| FY Dec 2023 | +11.8% |
| FY Dec 2022 | +17.0% |
| FY Dec 2021 | +19.7% |
| Jun 2026 | +11.2% |
| Mar 2026 | +9.6% |
| Dec 2025 | +7.9% |
| Sep 2025 | +12.3% |
| Jun 2025 | +4.2% |
| Mar 2025 | +5.5% |
| Dec 2024 | +8.9% |
| Sep 2024 | +0.3% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.17x
P/E over trailing EPS growth of 65%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing CAC
| FY Dec 2025 | 1.86x |
| FY Dec 2024 | 0.54x |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | 0.64x |
| Jun 2026 | 0.16x |
| Mar 2026 | 0.20x |
| Dec 2025 | 1.86x |
| Sep 2025 | 1.13x |
| Jun 2025 | 2.01x |
| Mar 2025 | 2.98x |
| Dec 2024 | 0.54x |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $41.7M | $35.7M | $33.6M | $33.3M |
| Net income | $65.2M | $53.0M | $43.4M | $61.4M |
| EPS (diluted) | 3.84 | 3.62 | 2.97 | 4.17 |
| Operating cash flow | $63.9M | $60.9M | $67.5M | $105.2M |
| Buybacks | $0 | $1.6M | $2.0M | $10.2M |
| Dividends paid | $28.5M | $24.6M | $24.5M | $23.5M |
SEC XBRL, fiscal years, as known on 2026-10-27
CAC Stock Sonar score 4/7 axes
Find similar shapesCompareCAC ranks highest on growth (80th percentile) and profitability (72nd), and lowest on financial health (23rd), among Banks peers.
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
